Gajuwaka Pharmaceuticals Private Limited
Founded: 2002
Status: Active
Designation: Director
SK
Surya Narayana Murthy Kandregula - Profile
Surya Narayana Murthy Kandregula, Director and Partner, with 4 companies.
About
Surya Narayana Murthy Kandregula
Surya Narayana Murthy Kandregula has 11 years in corporate governance. Holds Director and Partner roles. Currently with 3 companies, including Gajuwaka Pharmaceuticals Private Limited and Saimadhuri Properties Private Limited. Formerly with 1 company, such as Gajuwaka Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current Companies
3
Past Companies
1
Total Affiliations
4
Oldest Company Age
24
Companies Associated with Surya Narayana Murthy Kandregula
Current Companies
Saimadhuri Properties Private Limited
Founded: 2017
Status: Active
Designation: Director
Sri Saimadhuri Property Developers Llp
Founded: 2015
Status: Active
Designation: Partner
Previous Companies
Gajuwaka Pharmaceuticals Private Limited
Founded: 2002
Status: Active
Designation: Additional Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Surya Narayana Murthy Kandregula?
Surya Narayana Murthy Kandregula has 11 years in corporate governance. Holds Director and Partner roles. Currently with 3 companies, including Gajuwaka Pharmaceuticals Private Limited and Saimadhuri Properties Private Limited. Formerly with 1 company, such as Gajuwaka Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
What is Surya Narayana Murthy Kandregula's role in current companies?
Surya Narayana Murthy Kandregula is associated with 3 companies as Director and Partner.
What industries does Surya Narayana Murthy Kandregula specialize in?
Surya Narayana Murthy Kandregula has expertise in General Business.
How many years of experience does Surya Narayana Murthy Kandregula have?
Surya Narayana Murthy Kandregula has 11 years in corporate governance.